Semaglutide
12 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Semaglutide for alcoholism | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| Semaglutide for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for diabetes mellitus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
| Semaglutide for glucose intolerance | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for non-alcoholic fatty liver disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Semaglutide for obesity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 20 |
| Semaglutide for pediatric obesity | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for prediabetic state | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Semaglutide for pulmonary disease, chronic obstructive | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for renal insufficiency, chronic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |